The domestic box office is having its strongest year since the pandemic. That does not mean moviegoing has recovered.

U.S. box-office revenue reached $6.2 billion through Aug. 2, up 15% from the same period last year, according to Rentrak data reported by Reuters. But theaters sold an estimated 470.9 million tickets through the first 30 weeks of 2026, compared with 747.3 million over the same stretch of 2019.

That is roughly 37% fewer admissions even as revenue has moved much closer to its pre-pandemic level.

The gap matters because it changes what a theatrical recovery actually means. The industry is not simply rebuilding the old audience. It is learning to generate more revenue from fewer visits.

The economics are shifting from frequency to value per visit

The average adult ticket price reached $13.46 through July 30, according to EntTelligence data cited by Reuters. Premium-format admissions averaged $18.22.

Theater operators are also collecting more once customers arrive. Marcus Corp. reported that its average ticket price rose 7.8% in the first quarter, driven by strategic pricing and a higher mix of premium large-format screens. Concession revenue per person increased 2.4%. The company said same-store attendance increased 19.1% from the prior-year quarter, but the pricing gains show how much of the model now depends on monetizing the visit itself.

This is a familiar premiumization strategy: fewer transactions can still support growth if each transaction carries more value.

For cinemas, that means recliners, IMAX and other premium large formats, upgraded food and beverage, collectibles, merchandise and dynamic pricing are becoming more central to the economics of the business.

The theater is becoming an event product

The shift also reflects a change in consumer behavior.

Streaming gave audiences a much larger supply of inexpensive, convenient home entertainment. That did not eliminate demand for theaters. It raised the threshold for leaving home.

The theatrical experience increasingly has to justify itself as an event: a film with enough scale, cultural relevance or spectacle to feel meaningfully different from waiting to watch at home.

That helps explain why premium-format screenings have become so important. Audiences are not simply paying more for the same movie. They are paying for a version of the experience that cannot be replicated easily in a living room.

The result is a business model with more in common with live entertainment than the high-frequency moviegoing habit that defined much of the 20th century.

Revenue can recover before behavior does

Foot-traffic data reinforce the distinction. Placer.ai data cited by Reuters show U.S. theater attendance through July running 8.1% above 2025 but still 27% below 2019.

That is not a failed recovery. It is a different recovery.

For exhibitors, stronger revenue with lower attendance can still improve economics if pricing, premium mix and per-customer spending compensate for lost volume. For studios, however, the concentration of demand into fewer major theatrical moments can make performance more volatile.

A calendar with several breakout films can create record weekends. A weak slate can expose how much of the audience has stopped going to theaters by default.

That makes release strategy more consequential. A movie no longer competes only with other films opening around it. It competes with the consumer’s entire at-home entertainment environment.

The next question is how elastic premiumization becomes

The current model is working well enough to push the box office toward its strongest post-pandemic year. But pricing cannot rise indefinitely without affecting demand.

The industry therefore has to solve two problems at once: maintain enough event-level demand to justify premium pricing while also developing a broader slate that gives consumers reasons to return more often.

There are encouraging signs. This year’s strongest performers include not only familiar franchises but a wider mix of original and standalone films. That suggests consumers have not abandoned theatrical discovery entirely.

Still, the central business trend is clear.

Hollywood’s theatrical recovery is being measured in dollars faster than it is being measured in people.

That may prove durable. A smaller but higher-value audience can support a healthy business if exhibitors continue improving the experience and studios keep supplying enough films worth leaving home for.

But it is not a return to the old moviegoing economy. It is the emergence of a more premium, more event-driven one.